The battle against breast cancer is often framed through the lens of the patient—their resilience, their physical toll, and their ultimate triumph or loss. However, behind the statistics and the clinical reports lies a secondary, often invisible narrative: the journey of the caregiver. For Jessica and Matt Conwell, a diagnosis of triple-negative breast cancer (TNBC) was not merely a medical emergency; it was a profound test of a partnership forged over two decades, eventually sparking a massive philanthropic movement within the North American gaming community.
At 45 years old, Jessica Conwell faced a diagnosis that carries some of the most challenging prognoses in oncology. Her husband, Matt, an entrepreneur and community leader, found himself thrust into a dual role: a primary caregiver managing a life-threatening series of medical crises and a fundraiser leveraging his professional network to ensure that future families might face better odds. This is the story of how personal trauma can be transmuted into systemic support through the power of community and the relentless pursuit of scientific research.
Main Facts: The Intersection of Personal Crisis and Public Advocacy
The narrative of the Conwell family is defined by three primary pillars: a high-stakes medical battle, the psychological burden of the caregiver, and the mobilization of a niche community for a global cause.
In June 2022, Jessica Conwell was diagnosed with triple-negative breast cancer (TNBC). This subtype is characterized by the absence of estrogen and progesterone receptors and low levels of the HER2 protein. Because the cancer does not respond to hormonal therapies or medicines that target HER2, it is notoriously difficult to treat and has a higher rate of recurrence and metastasis than other forms of breast cancer.
Matt Conwell, Jessica’s husband of 26 years, is the founder of the Portland Local Area Network (PDXLAN), one of the largest community gaming events in North America. Following Jessica’s diagnosis and subsequent near-fatal complications, Matt pivoted the focus of his organization toward the Breast Cancer Research Foundation (BCRF). To date, the PDXLAN community has raised over $91,000 for BCRF, directly funding the research into the very treatments that saved Jessica’s life.
Chronology: A Two-Year Odyssey of Survival
The Conwells’ journey began in the summer of 2022, but the roots of their resilience were planted years prior. Meeting at a college retreat in 1996 and marrying in 1998, the couple built a life in the Pacific Northwest centered on mutual support.
The Diagnosis (June 2022)
Jessica’s routine annual mammogram in June 2022 led to a harrowing follow-up. A biopsy confirmed the presence of TNBC. For Matt, the news was compounded by a family history of the disease. "When I looked at the statistics, I thought I was going to lose her," he recalled. The aggressive nature of TNBC meant that treatment had to be immediate and intensive.
The "Anniversary" Treatment (August 2022 – January 2023)
On August 1, 2022—the couple’s 24th wedding anniversary—Jessica began her first round of chemotherapy. This period was marked by the grueling side effects of cytotoxic drugs designed to shrink the tumor before surgical intervention. In January 2023, Jessica underwent a double mastectomy. While the surgery was successful, pathology reports revealed that the cancer had already begun to spread to her lymph nodes, necessitating a more aggressive post-surgical radiation and treatment plan.
The Secondary Crisis: Sepsis and Gangrene (April 2023)
The most harrowing chapter of their story occurred not due to the cancer itself, but a rare and lethal complication. In April 2023, Jessica developed Fournier’s gangrene, an acute, rapidly progressing necrotizing fasciitis. The infection led to septic shock, a condition where the body’s immune response causes widespread organ failure and a catastrophic drop in blood pressure.
Jessica spent 61 days in the hospital, undergoing multiple emergency surgeries to debride infected tissue. During this time, the medical team remained uncertain if she would survive. Remarkably, through a feat of interdisciplinary medical coordination, Jessica continued her radiation treatments for TNBC while fighting for her life in the intensive care unit.
Recovery and the "New Normal" (2024 and Beyond)
Following her discharge, Jessica faced a months-long recovery process at home. While she is currently in a state of "no evidence of disease" (NED), the psychological shadows of the past two years remain. Matt transitioned from a crisis manager to a long-term caregiver, grappling with the emotional aftermath of the trauma.
Supporting Data: The Reality of Triple-Negative Breast Cancer (TNBC)
To understand the weight of the Conwells’ experience, one must look at the clinical data surrounding TNBC. This subtype accounts for approximately 10% to 15% of all breast cancer cases.
- Aggression and Recurrence: TNBC is more likely to spread outside the breast and is more likely to recur after treatment than other types. The risk of recurrence is highest in the first three to five years following diagnosis.
- Demographics: It disproportionately affects younger women (under age 40) and Black women. Jessica’s diagnosis at 45 places her in a demographic where the disease is increasingly being identified earlier than in previous decades.
- Treatment Limitations: Because TNBC lacks the three most common receptors known to fuel most breast cancer growth, "targeted" therapies like Tamoxifen or Herceptin are ineffective. Treatment relies heavily on a combination of surgery, radiation, and intensive chemotherapy.
Matt Conwell’s emphasis on research is backed by the fact that many of the immunotherapy drugs now used to treat TNBC—such as Pembrolizumab (Keytruda)—were only approved by the FDA in the last few years. These breakthroughs are the direct result of funding provided by organizations like the BCRF.
Official Responses: The Caregiver’s Burden and Mental Health
One of the most significant aspects of Matt Conwell’s advocacy is his focus on the mental health of the caregiver. In interviews with the BCRF, Matt highlighted the concept of "anticipatory grief"—the experience of mourning a loved one who is still alive but whose future is uncertain.
"I cried daily for months," Matt admitted. He noted that while the patient is the focus of clinical care, the caregiver often operates in a vacuum of emotional support. "There can be a stigma around men asking for help. I wish everyone had someone they could talk to about the things they fear."
Mental health professionals suggest that caregivers of cancer patients experience rates of depression and anxiety that often mirror or exceed those of the patients themselves. Matt’s decision to speak openly about his struggle is an attempt to dismantle the "stoic" archetype of the male caregiver, encouraging a more transparent dialogue about the emotional labor involved in long-term medical crises.
Implications: The Power of Niche Communities in Philanthropy
The transformation of PDXLAN into a fundraising powerhouse for breast cancer research offers a blueprint for modern philanthropy. Founded by Matt in 2003 as a class project during his MBA program, PDXLAN grew into a massive gathering where 1,000 PC gamers meet for four days of community and competition.
From Gaming to Giving
Under Matt’s leadership, the organization moved beyond simple entertainment. By integrating charity drives into the events, PDXLAN tapped into the "tribal" loyalty of the gaming community. Since 2017, the organization’s $91,000 contribution to the BCRF has funded roughly 1,820 hours of laboratory research.
The Research Imperative
The Conwell story underscores a critical reality: scientific research is the only bridge between a terminal diagnosis and a chronic, manageable condition. Matt’s advocacy is built on the realization that Jessica’s survival was predicated on drugs that did not exist a decade ago.
"Those drugs are all based on scientific research," Matt says. "To the scientists and doctors working on these breakthroughs: Thank you. You don’t know how much it means to families like ours."
A Call to Early Action
As breast cancer rates rise among younger populations, the Conwells’ experience serves as a stark reminder of the importance of early detection and the necessity of continued funding. The "If not us, who?" mentality adopted by Matt has turned a private tragedy into a public benefit.
Conclusion
Jessica Conwell’s journey through TNBC and septic shock is a testament to the advancements of modern medicine, but Matt Conwell’s journey as her partner is a testament to the power of human connection. By bridging the gap between the sterile environment of the oncology ward and the vibrant, digital world of the gaming community, the Conwells have ensured that their struggle serves a higher purpose.
As Jessica moves forward with hope and resilience, the $91,000 raised by PDXLAN continues to work in labs across the country, seeking the next breakthrough for the 15% of women who, like Jessica, face the unique challenges of triple-negative breast cancer. For the Conwells, the message is clear: survival is a team sport, and the community is the ultimate support system.
About the Author
